Myriad Complications update

Yesterday we  reported that Myriad Genetics had filed a suit alleging patent infringement against Ambry Genteics. Myriad has followed up with an additional suit against Gene by Gene Ltd. in the District of Utah, Central Division.

Since our angle in yesterday's posting was price comparison between Myriad's "Brand Name" BRCA1/2 testing and "Generic" competitors, we wondered  how much Gene by Gene Ltd. charges for their test.  According to an online press release, Gene by Gene will be charging $995 for BRCA1/BRCA2 testing in the US.